Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer
Clinical trial NCT04576143 · RECRUITING
Trial details
- NCT number
- NCT04576143
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-20
- Primary completion
- 2023-06-20
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.